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Background
There is debate regarding whether surgical resection
and/or lymphadenectomy are indicated for small non-
functional pancreatic neuroendocrine tumors (PNETs).
Myeloid cell population expansion in peripheral blood
has been correlated with clinical stage of patients with
solid tumors. We aim to determine if blood sampling
can be used as a predictor of malignant potential in
nonfunctional PNETs.
Methods
We prospectively measured cell counts in 29 patients
with PNET using flow cytometry of fresh whole blood
before and after surgery, including CD3+, CD8+, and
CD4+ T cells; monocytes; and granulocytes. Correlations
were sought with known clinical markers of malignant
potential such as tumor size, grade, number of positive
lymph nodes, and TNM stage using t-test and one-way
ANOVA analysis (STATA Inc).
Results
In this small cohort of patients, there were no differ-
ences in circulating immune cell counts between
patients with lymph node metastases versus those with-
out, nor in patients with tumors > 2cm, nor in those
patients with high grade tumors. Interestingly, patients
with lymph node metastases had a significant decrease
in number of circulating CD8+ T cells post operatively
when compared to those with negative lymph nodes
(p = 0.013). There was a similar decrease in monocyte
count post operatively in patients with positive versus
negative lymph nodes that did not reach significance
(p = 0.056).
Conclusions
Our data do not provide evidence that circulating
immune cell populations can be used as biomarkers of
lymph node positivity or of malignant potential in
PNET prior to resection.
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